Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-2584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients ; volume:50 ; number:2 ; day:8 ; month:1 ; year:2018 ; pages:339-345 ; date:2.2018
International urology and nephrology ; 50, Heft 2 (8.1.2018), 339-345, 2.2018
- Urheber
-
Wlazeł, Rafał Nikodem
- Beteiligte Personen und Organisationen
-
Szadkowska, Iwona
Bartnicki, Piotr
Rośniak-Bąk, Kinga
Rysz, Jacek
SpringerLink (Online service)
- DOI
-
10.1007/s11255-017-1778-5
- URN
-
urn:nbn:de:101:1-2018090914145918823077
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wlazeł, Rafał Nikodem
- Szadkowska, Iwona
- Bartnicki, Piotr
- Rośniak-Bąk, Kinga
- Rysz, Jacek
- SpringerLink (Online service)
Ähnliche Objekte (12)
Urokinase-type plasminogen activator receptor in vascular calcification
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Regulation of the human urokinase type plasminogen activator receptor gene
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
Soluble Urokinase Plasminogen Activator Receptor is Associated with Coronary Artery Calcification and Cardiovascular Disease in Patients Undergoing Hemodialysis
Urokinase-type plasminogen activator receptor in vascular calcification
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Regulation of the human urokinase type plasminogen activator receptor gene
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
Soluble Urokinase Plasminogen Activator Receptor is Associated with Coronary Artery Calcification and Cardiovascular Disease in Patients Undergoing Hemodialysis
Urokinase-type plasminogen activator receptor in vascular calcification
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Regulation of the human urokinase type plasminogen activator receptor gene
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator